Hello and welcome to the details of Novartis CEO: Malaria drug biggest hope against coronavirus, SonntagsZeitung reports and now with the details
ZURICH, March 29 — Novartis Chief Executive Vas Narasimhan said his Sandoz generics unit's malaria, lupus and arthritis drug hydroxychloroquine is the company's biggest hope against the coronavirus, Swiss newspaper SonntagsZeitung reported today.
Novartis has pledged to donate 130 million doses and is supporting clinical trials needed before the medicine, which US President Donald Trump also has been promoting, can be approved for use against the coronavirus.
Other companies including Bayer and Teva have also agreed to donate hydroxychloroquine or similar drugs, while Gilead Sciences is testing its experimental drug remdesivir against coronavirus.
“Pre-clinical studies in animals as well as the first data from clinical studies show that hydroxychloroquine kills the coronavirus,” Narasimhan told the newspaper. “We're working with Swiss hospitals on possible treatment protocols for the clinical use of the drug, but it's too early to say anything definitively.”
He said the company is currently looking for additional active drug ingredients to make more hydroxychloroquine, should clinical trials be successful.
Narasimhan said three other Novartis drugs — Jakavi for cancer, multiple sclerosis drug Gilenya and fever drug Ilaris — are being studied for their effect on complications related to Covid-19, the newspaper reported.
This follows separate efforts to re-purpose drugs made by companies including Roche and Sanofi to treat complications related to the disease. — Reuters
These were the details of the news Novartis CEO: Malaria drug biggest hope against coronavirus, SonntagsZeitung reports for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at Malay Mail and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.